Cash Flow from Investing Activities (Quarterly)

Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.

Sarepta Therapeutics, Inc. (SRPT) had Cash Flow from Investing Activities of $-134.39M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$730.80M
Net Income	$330.96M
Cost of Goods Sold	$108.77M
Gross Profit	$622.03M
Operating Expenses	$372.37M
Operating Income	$358.43M
Non-Operating Income/Expense	$-15.26M
Pre-Tax Income	$343.17M
Normalized Pre-Tax Income	$343.17M
Income after Taxes	$330.96M
Income from Continuous Operations	$330.96M
Consolidated Net Income/Loss	$330.96M
Normalized Income after Taxes	$330.96M
EBIT	$358.43M
EBITDA	$368.50M
Weighted-Average Shares Outstanding (Basic)	104.99M
Weighted-Average Shares Outstanding (Diluted)	121.92M
Earnings per Share (EPS) (Basic)	$3.15
Earnings per Share (EPS) (Diluted)	$2.88
Balance Sheet Financials
Current Assets	$2.31B
Property, Plant, and Equipment	$336.24M
Long-Term Assets	$869.06M
Total Assets	$3.18B
Current Liabilities	$499.16M
Long-Term Debt	$838.16M
Long-Term Liabilities	$1.17B
Total Liabilities	$1.67B
Common Equity	$1.51B
Tangible Shareholders Equity	$1.51B
Shareholders Equity	$1.51B
Common Shares Outstanding	105.57M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-202.68M
Cash Flow from Investing Activities	$-134.39M
Cash Flow from Financial Activities	$0.24M
Beginning Cash	$814.41M
End Cash	$477.57M
Increase/Decrease in Cash	$-336.83M
Stock-Based Compensation	$29.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.63
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	0.56
Gross Margin	85.12%
Operating Margin	49.05%
EBIT Margin	49.05%
EBITDA Margin	--
Pre-Tax Profit Margin	46.96%
Profit Margin	45.29%
Free Cash Flow	$-204.76M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.23
Inventory Turnover	0.11
Receiveable Turnover	1.85
Days Sales in Receivables	48.62
Return on Equity	21.99%
Return on Tangible Equity	21.99%
Return on Assets	10.41%
Return on Investments	14.12%
Book Value Per Share	$14.26
Free Cash Flow per Share	$-1.68
Operating Cash Flow per Share	$-1.66

Data from Zacks Investment Research, Inc.